Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam in Patients Receiving Continuous Renal Replacement Therapy in Intensive Care

NCT07167524 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT07167524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam in Patients Receiving Continuous Renal Replacement Therapy in Intensive Care
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
April 1, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, severe bacterial infections